Online Abstract Submission
for
ACTRIMS 2006

Basic and Clinical Issues in
Multiple Sclerosis Research
 
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Hyatt Regency Chicago
Chicago, Illinois, USA
Sunday, October 8, 2006

ABSTRACT SUBMISSION GUIDELINES

You are invited to submit a competitive abstract for a platform or poster presentation for ACTRIMS 2006. Abstracts may only be submitted online. The submission site will open May 1, 2006. The abstract submission deadline is 11:59 pm Pacific Time, June 5, 2006.

Authors will be asked to select a category that best describes their abstract submission:
  • Disease Modifying Therapy
  • Epidemiology/Genetics
  • Experimental Disease Models
  • Imaging
  • Neuroimmunology
  • Neuropsychology/Neuropsychiatry
  • Pathology
  • Rehabilitation and Quality of Life
  • Surrogate Markers (non-MRI)
  • Symptom Management
Abstracts will be evaluated on the basis of originality, significance, relevance to MS, and scientific/technical merit.

Presenting authors will be contacted by July 31, 2006, regarding whether or not an abstract has been accepted. Presenting authors must register for the meeting. Accepted abstracts will be published in the journal Multiple Sclerosis: Clinical and Laboratory Research.
 
Presentation Types
Poster Presentations
Up to 20 abstracts will be selected for poster display and the presenting authorwill be provided a complimentary registration to the meeting. The presenting author will stand by the poster and be available to answer questions during the poster session.
 
Platform Presentations
Up to six abstracts will be selected for presentation at the platform. The presenting author will be invited to make a 15-minute presentation (including questions). The presenting author will receive a travel grant of US$500, payable after the meeting, and will be provided a complimentary registration to the meeting.
 

Guidelines for Preparation of Abstracts

  • The presenting author must be the contact author.
  • Abstract must be submitted in English.
  • Please plan to create and save the abstract using your customary word processor and to copy/paste the information onto the abstract processing site.
  • Use a short specific title indicating the nature of the investigation. Do not include abbreviations in the title.
  • Abstract should clearly address the following points: background, objectives, methods, results, and conclusions.
  • Authors will be asked to select the category that best describes their abstract submission.
  • Provide six index terms (keywords), not including "multiple sclerosis" or "MS."
  • Maximum abstract length is 2500 characters--which includes the title, authors, and affiliations.
  • Tables, figures, and references are not allowed.
  • Disclosure of conflict of interest (e.g., grant support, consultancy, membership on advisory councils, speaker's bureau, etc.) and source of funding is required.
  • Use generic drug names.
  • Standard abbreviations may be used without definition. Nonstandard abbreviations must be placed in parentheses after first use of the term in the abstract body.
  • Proof-read your abstract to make sure it is accurate. If selected, it will be published as submitted.
  • Click here for suggestions if you are behind a firewall
Submit an abstract
   
 
Click here if you have already submitted an abstract title -- and you wish to view, resume, edit, or withdraw that submission.


Technical support may be obtained by calling 401-334-0220 between 8:30 AM and 6 PM Eastern Standard Time, Monday-Friday; or email tech support at any time.
 
 
For questions regarding abstract submission guidelines please contact:
ACTRIMS c/o
National Multiple Sclerosis Society
Phone: 212-476-0469
E-Mail: actrims@nmss.org